血清粉样蛋白A蛋白与血脑屏障的相互作用:对中枢神经系统疾病的影响
Michelle A Erickson1,2, Anvitha P Mahankali2
1Geriatric Research Education and Clinical Center, VA Puget Sound Healthcare System, Seattle, WA 98108, USA.
International journal of molecular sciences
|June 27, 2024
概括
血清粉样蛋白A (SAA) 蛋白通过穿越血脑屏障 (BBB) 影响大脑. 这次审查探讨了SAA的SAA.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 血清粉样蛋白A (SAA) 蛋白质是参与急性阶段反应和粉样症的脂蛋白.
- 它们的精确生物功能仍然不完全理解.
- 已经证明SAA蛋白可以穿越血脑屏障 (BBB).
研究的目的:
- 审查关于SAA蛋白,神经炎症和中枢神经系统 (CNS) 疾病之间的关系的现有文献.
- 讨论BBB在中枢神经系统中SAA影响中介方面的潜在作用.
主要方法:
- 对研究SAA蛋白质在中枢神经系统疾病和神经炎症的背景下进行的文献综述.
- 对SAA蛋白质在BBB中的运输及其功能后果的研究分析.
主要成果:
- SAA蛋白可以通过穿越完整的BBB进入中枢神经系统.
- SAA 蛋白质可能会损害 BBB 功能.
- 在中枢神经系统中,SAA蛋白具有保护性和有害性.
结论:
- SAA蛋白在神经炎症和中枢神经系统疾病中起着复杂的作用.
- BBB是影响SAA对大脑影响的关键接口.
- 需要进一步的研究来充分阐明SAA在中枢神经系统中的功能及其治疗潜力.
更多相关视频
06:19Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
2.0K
07:22Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
Published on: November 8, 2017
9.9K
相关概念视频
The Blood-brain Barrier
47.2K
Overview
47.2K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Drug Binding to Blood Components
141
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
141
